Scinai Immunotherapeutics (SCNI) Stock Price, Quote, News & History

Key Statistics

Open

$1.84

Volume / Avg.

1.02M / 790.81K

Day Range

$1.53 - $1.88

52 Wk Range

1.60 - 16.40

Market Cap

$1.25M

P/E Ratio

0.09

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.26%

Days to Cover

Recent Scinai Immunotherapeutics Ltd News

Why Veea Shares Are Trading Higher By 58%; Here Are 20 Stocks Moving Premarket

Veea shares surged 58% premarket on a NovaGen merger plan and $10M GeoNova investment, while other stocks posted notable gains and losses.

Avi Kapoor

Nasdaq Down Over 200 Points; Cellectis Shares Plunge

U.S. stocks fell Monday, led by a 2% tech decline. Nvidia may invest $10B in Anthropic; oil jumped 4.2%, while European markets mostly slipped.

Avi Kapoor

Why Scholar Rock Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Scholar Rock surged 11.9% after FDA approved ISEMBYLD for SMA; Scinai, Intercont and Rum led premarket gainers, while Picocela fell.

Avi Kapoor

Why Snowflake Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket

Snowflake shares surged 24% after Q2 revenue and earnings beat estimates; other premarket gainers and losers made notable moves.

Avi Kapoor

Why Organon Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Organon & Co (OGN) jumped 14.8% in pre-market trading as Sun Pharma agreed to acquire the company for $11.75 billion, $2 higher than current price.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-7.38M

Investing Cash Flow (TTM)

2.62M

Financing Cash Flow (TTM)

6.52M

Free Cash Flow (TTM)

-7.50M

Capital Expenditure (TTM)

-127.00K

Net Change in Cash (TTM)

1.76M

Valuation Metrics

Enterprise Value

$8.19M

PE Ratio (TTM)

0.09

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.86

PB Ratio (TTM)

0.27

Earnings Yield % (TTM)

1159.76%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$9.01

Company Debt

Total Debt

$285.00K

LT Debt

$285.00K

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$2.65M

Debt to Equity

0.59

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$1.84

Volume / Avg.

1.02M / 790.81K

Day Range

$1.53 - $1.88

52 Wk Range

1.60 - 16.40

Market Cap

$1.25M

P/E Ratio

0.09

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.26%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organiz...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

SCNI

ABBV

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

SCNI

ABBV

FAQ

How do I buy Scinai Immunotherapeutics (SCNI) stock?

You can purchase shares of Scinai Immunotherapeutics (NASDAQ:SCNI) through any online brokerage.

View our list of the best stock brokerages

Who are Scinai Immunotherapeutics (SCNI) competitors?

Other companies in Scinai Immunotherapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

What is the forecast, or price target, for Scinai Immunotherapeutics (SCNI) stock?

There is no analysis for Scinai Immunotherapeutics to provide a consensus price target.

What is the current price for Scinai Immunotherapeutics (SCNI)?

The stock price for Scinai Immunotherapeutics (NASDAQ: SCNI) is $1.85 last updated September 15, 2026 at 9:29 AM EDT.

Does Scinai Immunotherapeutics (SCNI) pay a dividend?

There are no upcoming dividends for Scinai Immunotherapeutics.

When is Scinai Immunotherapeutics (NASDAQ:SCNI) reporting earnings?

Scinai Immunotherapeutics does not have any upcoming earnings scheduled.

Is Scinai Immunotherapeutics (SCNI) going to split?

There is no upcoming split for Scinai Immunotherapeutics.

What sector and industry does Scinai Immunotherapeutics (SCNI) operate in?

Scinai Immunotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Scinai Immunotherapeutics Ltd (SCNI) Stock Price, Quote, News & History

Scinai Immunotherapeutics (SCNI) Stock Price, Quote, News & History | Benzinga

Key Statistics

Recent Scinai Immunotherapeutics Ltd News

Why Veea Shares Are Trading Higher By 58%; Here Are 20 Stocks Moving Premarket

Nasdaq Down Over 200 Points; Cellectis Shares Plunge

Why Scholar Rock Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Why Snowflake Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket

Why Organon Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Financials

Cash Flows

Valuation Metrics

Company Debt

Key Statistics

About

Edge Rankings

Stock Score Locked: Want to See it?

Compare

FAQ

How do I buy Scinai Immunotherapeutics (SCNI) stock?

Who are Scinai Immunotherapeutics (SCNI) competitors?

What is the forecast, or price target, for Scinai Immunotherapeutics (SCNI) stock?

What is the current price for Scinai Immunotherapeutics (SCNI)?

Does Scinai Immunotherapeutics (SCNI) pay a dividend?

When is Scinai Immunotherapeutics (NASDAQ:SCNI) reporting earnings?

Is Scinai Immunotherapeutics (SCNI) going to split?

What sector and industry does Scinai Immunotherapeutics (SCNI) operate in?